Concepedia

Publication | Open Access

Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin

DOIFull Paper Access

27

Citations

52

References

2020

Year

Manga Motrapu, Monika Świderska, Irene Mesas, Julian A. Marschner, Yutian Lei, Laura Martínez Valenzuela, Jia Fu, Kyung Lee, Maria Lucia Angelotti, Giulia Antonelli,
Journal of the American Society of Nephrology

Abstract

Add-on treatment with BIO for only 4 weeks attenuates progression of CKD beyond MRE therapy in mice with type 2 diabetes. Additional drug combinations may help to further delay ESKD in type 2 diabetes.

References

YearCitations

Page 1